| 1 |
Friedrich M, Pohin M, Powrie F. Cytokine networks in the pathophysiology of inflammatory bowel disease[J]. Immunity, 2019, 50(4):992-1006.
|
| 2 |
Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies[J]. Lancet, 2018, 390(10114):2769-2778.
|
| 3 |
Ouyang Q, Tandon R, Goh KL, et al. Management consensus of inflammatory bowel disease for the Asia-Pacific region[J]. J Gastroenterol Hepatol, 2006, 21(12):1772-1782.
|
| 4 |
Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn's disease in the Chinese population[J]. Inflamm Bowel Dis, 2004, 10(5):646-651.
|
| 5 |
Shah J, Thakur ML, Dutta U. Mucosal healing in inflammatory bowel disease: Expanding horizon[J]. Indian J Gastroenterol, 2019, 38(2):98-109.
|
| 6 |
Mao F, Tu Q, Wang L, et al. Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease[J]. Oncotarget, 2017, 8(23):38008-38021.
|
| 7 |
Rieder F, Fiocchi C, Rogler G. Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases[J]. Gastroenterology, 2017, 152(2,):340-350.e6
|
| 8 |
Friedenstein AJ, Chailakhyan RK, Gerasimov UV. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers[J]. Cell Tissue Kinet, 1987, 20(3):263-272.
|
| 9 |
Caplan AI. Mesenchymal stem cells[J]. J Orthop Res, 1991, 9(5):641-650.
|
| 10 |
Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells[J]. Science, 1999, 284(5411):143-147.
|
| 11 |
Bellavia M, Altomare R, Cacciabaudo F, et al. Towards an ideal source of mesenchymal stem cell isolation for possible therapeutic application in regenerative medicine[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2014, 158(3):356-360.
|
| 12 |
Patki S, Kadam S, Chandra V, et al. Human breast milk is a rich source of multipotent mesenchymal stem cells[J]. Hum Cell, 2010, 23(2):35-40.
|
| 13 |
Shih DT, Lee DC, Chen SC, et al. Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue[J]. Stem Cells, 2005, 23(7):1012-1020.
|
| 14 |
Takebe Y, Tatehara S, Fukushima TA, et al. Cryopreservation method for the effective collection of dental pulp stem cells[J]. Tissue Eng Part C Methods, 2017, 23(5):251-261.
|
| 15 |
Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system[J]. Nat Rev Immunol, 2012, 12(5):383-396.
|
| 16 |
Horwitz EM, Le Blanc K, Dominici M, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement[J]. Cytotherapy, 2005, 7(5):393-395.
|
| 17 |
Dave M, Mehta K, Luther J, et al. Mesenchymal stem cell therapy for inflammatory bowel disease: a systematic review and meta-analysis[J]. Inflamm Bowel Dis, 2015, 21(11):2696-2707.
|
| 18 |
Mias C, Lairez O, Trouche E, et al. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction[J]. Stem Cells, 2009, 27(11):2734-2743.
|
| 19 |
Wang XD, Zhao W, Wang JH, et al. Bone marrow stromal cells inhibit the activation of liver cirrhotic Fat-Storing cells via adrenomedullin secretion[J]. Dig Dis Sci, 2015, 60(5):1325-1334.
|
| 20 |
Falavigna A, da Costa JC. Mesenchymal autologous stem cells[J]. World Neurosurg, 2015, 83(2):236-250.
|
| 21 |
Balsam LB, Wagers AJ, Christensen JL, et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium[J]. Nature, 2004, 428(6983):668-673.
|
| 22 |
Ranganath SH, Levy O, Inamdar MS, et al. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease[J]. Cell Stem Cell, 2012, 10(3):244-258.
|
| 23 |
González MA, Gonzalez-Rey E, Rico L, et al. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses[J]. Gastroenterology, 2009, 136(3):978-989.
|
| 24 |
Volarevic V, Al-Qahtani A, Arsenijevic NA, et al. Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis[J]. Autoimmunity, 2010, 43(4):255-263.
|
| 25 |
Sun YQ, Deng MX, He J, et al. Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice[J]. Stem Cells, 2012, 30(12):2692-2699.
|
| 26 |
刘星星, 范恒, 唐庆, 等. 过表达cxcr4的间充质干细胞缓解实验性结肠炎[J]. 世界华人消化杂志, 2016, 24(08):1233-1240.
|
| 27 |
Delarosa O, Lombardo E, Beraza AA, et al. Requirement of IFN-gamma-mediated indoleamine 2,3-Dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells[J]. Tissue Eng Part A, 2009, 15(10):2795-2806.
|
| 28 |
Phinney DG, Pittenger MF. Concise review: MSC-Derived exosomes for Cell-Free therapy[J]. Stem Cells, 2017, 35(4):851-858.
|
| 29 |
陈筑昕, 周双白, 李青峰. 脂肪干细胞来源外泌体促进组织修复的应用进展[J]. 组织工程与重建外科杂志, 2018, 14(04):219-222.
|
| 30 |
Yang J, Liu XX, Fan H, et al. Extracellular vesicles derived from bone marrow mesenchymal stem cells protect against experimental colitis via attenuating colon inflammation, oxidative stress and apoptosis[J]. PLoS One, 2015, 10(10):e0140551.
|
| 31 |
Zou X, Zhang G, Cheng Z, et al. Microvesicles derived from human Wharton's Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1[J]. Stem Cell Res Ther, 2014, 5(2):40.
|
| 32 |
Le Blanc K, Ringdén O. Immunomodulation by mesenchymal stem cells and clinical experience[J]. J Intern Med, 2007, 262(5):509-525.
|
| 33 |
Lanzoni G, Alviano F, Marchionni CA, et al. Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease[J]. Cytotherapy, 2009, 11(8):1020-1031.
|
| 34 |
Komori M, Tsuji S, Tsujii M, et al. Involvement of bone marrow-derived cells in healing of experimental colitis in rats[J]. Wound Repair Regen, 2005, 13(1):109-118.
|
| 35 |
Hayashi Y, Tsuji S, Tsujii M, et al. Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats[J]. J Pharmacol Exp Ther, 2008, 326(2):523-531.
|
| 36 |
Chen QQ, Yan L, Wang CZ, et al. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses[J]. World J Gastroenterol, 2013, 19(29):4702-4717.
|
| 37 |
He XW, He XS, Lian L, et al. Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice[J]. Dig Dis Sci, 2012, 57(12):3136-3144.
|
| 38 |
Zuo DM, Liu XX, Shou ZX, et al. Study on the interactions between transplanted bone marrow-derived mesenchymal stem cells and regulatory T cells for the treatment of experimental colitis[J]. Int J Mol Med, 2013, 32(6):1337-1344.
|
| 39 |
Qu B, Xin GR, Zhao LX, et al. Testing stem cell therapy in a rat model of inflammatory bowel disease: role of bone marrow stem cells and stem cell factor in mucosal regeneration[J]. PLoS One, 2014, 9(10):e107891.
|
| 40 |
Banerjee A, Bizzaro D, Burra P, et al. Umbilical cord mesenchymal stem cells modulate dextran sulfate Sodium induced acute colitis in immunodeficient mice[J]. Stem Cell Res Ther, 2015, 6:79.
|
| 41 |
Robinson AM, Miller S, Payne N, et al. Neuroprotective potential of mesenchymal stem Cell-Based therapy in acute stages of TNBS-Induced colitis in Guinea-Pigs[J]. PLoS One, 2015, 10(9):e0139023.
|
| 42 |
Xie MH, Qin HB, Luo QX, et al. Comparison of Adipose-Derived and bone marrow mesenchymal stromal cells in a murine model of crohn's disease[J]. Dig Dis Sci, 2017, 62(1):115-123.
|
| 43 |
Lian L, Huang QS, Zhang LJ, et al. Anti-fibrogenic Potential of Mesenchymal Stromal Cells in Treating Fibrosis in Crohn's Disease[J]. Dig Dis Sci, 2018, 63(7):1821-1834.
|
| 44 |
Nam YS, Kim N, Im KI, et al. Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis[J]. World J Gastroenterol, 2015, 21(7):2030-2039.
|
| 45 |
Chinnadurai R, Ng S, Velu V, et al. Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease[J]. World J Gastroenterol, 2015, 21(16):4779-4787.
|
| 46 |
Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: an update[J]. Cell Transplant, 2016, 25(5):829-848.
|
| 47 |
王玉明, 张晓琦, 于成功. 间充质干细胞在炎症性肠病治疗中的研究进展[J]. 胃肠病学, 2018, 23(02):101-104.
|
| 48 |
García-Olmo D, García-Arranz M, Herreros D, et al. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation[J]. Dis Colon Rectum, 2005, 48(7):1416-1423.
|
| 49 |
Ciccocioppo R, Bernardo ME, Sgarella A, et al. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease[J]. Gut, 2011, 60(6):788-798.
|
| 50 |
Panés J, García-Olmo D, Van Assche G, et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial[J]. Lancet, 2016, 388(151):1281-1290.
|
| 51 |
Molendijk I, Bonsing BA, Roelofs H, et al. Allogeneic bone Marrow-Derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with crohn's disease[J]. Gastroenterology, 2015, 149(4):918-927.e6.
|
| 52 |
Zhang J, Lv SM, Liu XJ, et al. Umbilical cord mesenchymal stem cell treatment for crohn's disease: a randomized controlled clinical trial[J]. Gut Liver, 2018, 12(1):73-78.
|
| 53 |
Liang J, Zhang H, Wang D, et al. Allogeneic mesenchymal stem cell transplantation in seven patients with refractory inflammatory bowel disease[J]. Gut, 2012, 61(3):468-469.
|
| 54 |
Forbes GM, Sturm MJ, Leong RW, et al. A phase 2 study of allogeneic mesenchymal stromal cells for luminal crohn's disease refractory to biologic therapy[J]. Clin Gastroenterol Hepatol, 2014, 12(1):64-71.
|
| 55 |
Dhere T, Copland I, Garcia M, et al. The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease - a phase 1 trial with three doses[J]. Aliment Pharmacol Ther, 2016, 44(5):471-481.
|
| 56 |
Bernardo ME, Avanzini MA, et al. Phenotypical/functional characterization of in vitro-expanded mesenchymal stromal cells from patients with crohn's disease[J]. Cytotherapy, 2009, 11(7):825-836.
|
| 57 |
Dietz AB, Dozois EJ, Fletcher JG, et al. Autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with crohn's disease[J]. Gastroenterology, 2017, 153(1): 59-62.e2.
|
| 58 |
Castelo-Branco MT, Soares ID, Lopes DV, et al. Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis[J]. PLoS One, 2012, 7(3):e33360.
|
| 59 |
Barbash IM, Chouraqui P, Baron J, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium - Feasibility, cell migration, and body distribution[J]. Circulation, 2003, 108(7):863-868.
|
| 60 |
Sala E, Genua M, Petti L, et al. Mesenchymal stem cells reduce colitis in mice via release of TSG6, independently of their localization to the intestine[J]. Gastroenterology, 2015, 149(1):163-176.e20.
|
| 61 |
Hu XY, Wu RR, Jiang Z, et al. Leptin signaling is required for augmented therapeutic properties of mesenchymal stem cells conferred by hypoxia preconditioning[J]. Stem Cells, 2014, 32(10):2702-2713.
|
| 62 |
Katsuda T, Ochiya T. Molecular signatures of mesenchymal stem cell-derived extracellular vesicle-mediated tissue repair[J]. Stem Cell Res Ther, 2015, 6:212.
|
| 63 |
Fuenzalida P, Kurte M, Fernandez-O'ryan C, et al. Toll-like receptor 3 pre-conditioning increases the therapeutic efficacy of umbilical cord mesenchymal stromal cells in a dextran sulfate sodium-induced colitis model[J]. Cytotherapy, 2016, 18(5):630-641.
|
| 64 |
Yu Y, Zhao TY, Yang DQ. Cotransfer of regulatory T cells improve the therapeutic effectiveness of mesenchymal stem cells in treating a colitis mouse model[J]. Exp Anim, 2017, 66(2):167-176.
|
| 65 |
Duijvestein M, Molendijk I, Roelofs H, et al. Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease[J]. Cytotherapy, 2011, 13(9):1066-1073.
|